Overall Technical outlook

Price Summary

On 2026-02-27, Concord Biotech Limited's shares started at 1242.9, peaked at 1274.4, bottomed out at 1215.0, and ended -1.79% down at 1220.6, with 535622 shares traded.
The stock reached its highest price of 2130.4 and lowest price of 1076.1 over the last 52 weeks.
Based on recommendations from 6 analysts, the future price of CONCORDBIO is expected to range from 1170.0 to 1680.0, with an average price expectation around 1426.6666.

Technicals

Support and Resistance: The price for CONCORDBIO at 1220.6 is supported by the 1109.0 level and faces resistance at 1360.6. This range indicates key levels where the price may find buyers near 1109.0 and sellers near 1360.6, defining a trading range.
CONCORDBIO supportResistance 61d115
Support/Resistance for CONCORDBIO


Aroon: The AROON is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
CONCORDBIO aroon 61d115
Aroon chart for Concord Biotech Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
CONCORDBIO bbands 61d115
Bolinger Bands chart for Concord Biotech Limited


Parabolic SAR: The PSAR continues its bullish outlook, reinforcing a crucial support level that may help sustain the current upward trend. This support suggests that the market is likely to continue climbing, with the bullish momentum remaining strong.
CONCORDBIO psar 61d115
Parabolic Stop and Reverse chart for Concord Biotech Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
CONCORDBIO stoch 61d115
Stochastic chart for Concord Biotech Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position for Concord Biotech Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
CONCORDBIO trippleSMA 61d115
Tripple SMA chart for Concord Biotech Limited


Understanding a company's fundamentals—such as revenue, earnings, and debt levels—provides a solid foundation for analyzing its technical performance. Similarly, knowledge of the industry, including key competitors and market trends, is critical. Combining this fundamental analysis with technical indicators like stock charts, moving averages, and trading volume enables a more comprehensive approach to evaluating the company's overall health and potential future performance.